1. Home
  2. FNLC vs RCEL Comparison

FNLC vs RCEL Comparison

Compare FNLC & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNLC
  • RCEL
  • Stock Information
  • Founded
  • FNLC 1864
  • RCEL 2020
  • Country
  • FNLC United States
  • RCEL United States
  • Employees
  • FNLC N/A
  • RCEL N/A
  • Industry
  • FNLC Major Banks
  • RCEL Medical/Dental Instruments
  • Sector
  • FNLC Finance
  • RCEL Health Care
  • Exchange
  • FNLC Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • FNLC 295.4M
  • RCEL 308.6M
  • IPO Year
  • FNLC 1999
  • RCEL N/A
  • Fundamental
  • Price
  • FNLC $26.63
  • RCEL $12.79
  • Analyst Decision
  • FNLC
  • RCEL Buy
  • Analyst Count
  • FNLC 0
  • RCEL 4
  • Target Price
  • FNLC N/A
  • RCEL $19.33
  • AVG Volume (30 Days)
  • FNLC 18.0K
  • RCEL 117.4K
  • Earning Date
  • FNLC 01-22-2025
  • RCEL 02-20-2025
  • Dividend Yield
  • FNLC 5.36%
  • RCEL N/A
  • EPS Growth
  • FNLC N/A
  • RCEL N/A
  • EPS
  • FNLC 2.38
  • RCEL N/A
  • Revenue
  • FNLC $78,192,000.00
  • RCEL $60,040,000.00
  • Revenue This Year
  • FNLC N/A
  • RCEL $40.34
  • Revenue Next Year
  • FNLC N/A
  • RCEL $52.79
  • P/E Ratio
  • FNLC $11.49
  • RCEL N/A
  • Revenue Growth
  • FNLC N/A
  • RCEL 32.24
  • 52 Week Low
  • FNLC $21.77
  • RCEL $7.51
  • 52 Week High
  • FNLC $31.05
  • RCEL $18.93
  • Technical
  • Relative Strength Index (RSI)
  • FNLC 41.56
  • RCEL 52.40
  • Support Level
  • FNLC $26.91
  • RCEL $12.64
  • Resistance Level
  • FNLC $27.60
  • RCEL $13.95
  • Average True Range (ATR)
  • FNLC 0.79
  • RCEL 0.72
  • MACD
  • FNLC -0.10
  • RCEL 0.02
  • Stochastic Oscillator
  • FNLC 30.43
  • RCEL 56.23

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: